Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Carcinoma, Hepatocellular 3Recurrence 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Lymphoma 1Hepatitis B, Chronic 1Hepatitis B 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 18fludarabine 7Rituximab 7Etoposide 7Cytarabine 7Radiotherapy 5Peripheral Blood Stem Cell Transplantation 5Melphalan 5Filgrastim 5Cyclosporine 4Cisplatin 4fludarabine phosphate 3epratuzumab 3Vincristine 3Prednisone 3Methylprednisolone 3Indium 3Immunotherapy, Adoptive 3Doxorubicin 3Dexamethasone 3Busulfan 3Antilymphocyte Serum 3sargramostim 2Radioimmunodetection 2Paclitaxel 2Mycophenolic Acid 2Methotrexate 2Lym-1 monoclonal antibody 2Ifosfamide 2Hydrocortisone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Burkitt Lymphoma × Tenofovir × Clear all
NCT02585947 2016-12-21

To Compare the Efficacy of a Prophylactic Use of Tenofovir by Duration for the Non-Hodgkin's Lymphoma

Seoul National University Hospital

Phase 4 Unknown
90 enrolled
Lymphoid

Burkitt Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡